Literature DB >> 7575620

OK-1035, a selective inhibitor of DNA-dependent protein kinase.

Y Take1, M Kumano, Y Hamano, H Fukatsu, H Teraoka, S Nishimura, A Okuyama.   

Abstract

Screening for inhibitors of DNA-dependent protein kinase (DNA-PK) revealed 3-cyano-5-(4-pyridyl)-6-hydrazonomethyl-2-pyridone, designated OK-1035, to be a potent and selective inhibitor. When a synthetic peptide was used as a substrate, OK-1035 caused 50% inhibition of DNA-PK activity at 8 microM, a concentration more than 50 times lower than those required against seven other protein kinases tested. OK-1035 inhibited the phosphorylation by DNA-PK of consensus peptide as well as that of recombinant human wild type-p53. Kinetic studies indicated that OK-1035 inhibited DNA-PK activity in an ATP-competitive manner.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7575620     DOI: 10.1006/bbrc.1995.2431

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

Review 1.  Interaction of Ku protein and DNA-dependent protein kinase catalytic subunit with nucleic acids.

Authors:  W S Dynan; S Yoo
Journal:  Nucleic Acids Res       Date:  1998-04-01       Impact factor: 16.971

Review 2.  Development and Evolution of DNA-Dependent Protein Kinase Inhibitors toward Cancer Therapy.

Authors:  Yoshihisa Matsumoto
Journal:  Int J Mol Sci       Date:  2022-04-12       Impact factor: 6.208

Review 3.  The Role of the Core Non-Homologous End Joining Factors in Carcinogenesis and Cancer.

Authors:  Brock J Sishc; Anthony J Davis
Journal:  Cancers (Basel)       Date:  2017-07-06       Impact factor: 6.639

Review 4.  Enhancing anti-tumour innate immunity by targeting the DNA damage response and pattern recognition receptors in combination with radiotherapy.

Authors:  Charleen M L Chan Wah Hak; Antonio Rullan; Emmanuel C Patin; Malin Pedersen; Alan A Melcher; Kevin J Harrington
Journal:  Front Oncol       Date:  2022-08-29       Impact factor: 5.738

Review 5.  DNA Damage Signalling and Repair Inhibitors: The Long-Sought-After Achilles' Heel of Cancer.

Authors:  Denis Velic; Anthony M Couturier; Maria Tedim Ferreira; Amélie Rodrigue; Guy G Poirier; Fabrice Fleury; Jean-Yves Masson
Journal:  Biomolecules       Date:  2015-11-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.